HAII Secures Second Place in Prestigious KHIDI-Roche Diagnostics Day ‘New Impact Project,’ Eyes Global Expansion

Quick Summary:

In a remarkable achievement, HAII, a Seoul-based digital health innovator, secured second place at the KHIDI-Roche Diagnostics ‘New Impact Project.’ This prestigious event, known for spotlighting groundbreaking advancements in healthcare, recognized HAII for its pioneering work in digital biomarkers and AI-driven diagnostics.

Korean Startup and Technology News.

The company’s flagship product, Alzguard, leverages advanced AI to provide highly accurate dementia diagnostics, achieving an impressive 88% accuracy rate.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: StartupsTechnology

Markets: South KoreaUnited States

Topics: Series B funding K-FDA approval KHIDI-Roche Diagnostics Day Digital biomarkers Global Expansion Neurodegenerative diseases Digital Health Haii Alzguard AI-driven diagnostics

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-09 @ 09:25:48 (1 days ago)

News Timezone: GMT +8:00

News Source URL: koreatechdesk.com

Language: English

Article Length: 377 words

Reading Time: 3 minutes read

Sentences: 30 lines

Sentence Length: 13 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © KoreaTechDesk

News ID: 22002993

View Article Analysis

About KoreaTechDesk

Main Topics: StartupsTechnology

Official Website: koreatechdesk.com

Year Established: 2018

Headquarters: South Korea

News Last Updated: 3 days ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #90

Publisher Details

Frequently Asked Questions